Konstantin Semash

@bmtm.uz

Mini-invasive and transplant surgery department
National Children's Medical Center

Konstantin Semash


                           Download Compact PDF  
https://researchid.co/doctorsemash

EDUCATION

2012. Doctor of Medicine. First Moscow State Medical University. I. M. Sechenov. Moscow, Russia.
2014. Master of Surgery. First Moscow State Medical University. I. M. Sechenov. Moscow, Russia.
2016. General & Transplant Surgery Residency. V.I Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow, Russia
2020. PhD in Transplant Medicine. Thesis defense on the topic «Living Donor Laparoscopic Left Lateral Sectionectomy»

RESEARCH, TEACHING, or OTHER INTERESTS

Transplantation, Hepatology, Surgery, Pediatrics
38

Scopus Publications

349

Scholar Citations

10

Scholar h-index

11

Scholar i10-index

Scopus Publications

  • Neurological Complications After Pediatric Liver and Kidney Transplantation: A Comprehensive Review of Acute Symptomatic Seizures
    Konstantin Semash, Timur Dzhanbekov, Mansur Nasirov, Bakhtiyorjon Umarov, Navruz Qambarov, et al.
    Pediatric Transplantation, 2026
    Acute symptomatic seizures (ASS) represent one of the most frequent and clinically significant neurological complications following pediatric liver and kidney transplantation. Despite their clinical relevance, available evidence remains fragmented; pediatric‐specific data are limited, and no standardized diagnostic or management framework has been established. To summarize current evidence regarding the epidemiology, etiological mechanisms, diagnostic evaluation, risk factors, and management strategies of acute symptomatic seizures after pediatric liver and kidney transplantation, and to propose a practical clinical diagnostic and management algorithm. A structured narrative review with elements of a semi‐systematic approach was conducted using PubMed/MEDLINE, Scopus, and Web of Science databases. Studies published between 2000 and 2025 addressing neurological complications after pediatric liver and kidney transplantation were reviewed. Particular emphasis was placed on metabolic disturbances, calcineurin inhibitor neurotoxicity, posterior reversible encephalopathy syndrome (PRES), structural central nervous system lesions, infectious complications, hypertensive encephalopathy, dialysis disequilibrium syndrome, and uremic encephalopathy. Pediatric‐specific evidence was prioritized whenever available, while adult‐derived data were included for contextual interpretation when pediatric evidence was limited. The reported incidence of acute symptomatic seizures ranges from 2.8% to 42% after liver transplantation and up to 30% after kidney transplantation. In liver transplant recipients, the most common etiologies include calcineurin inhibitor neurotoxicity, metabolic disturbances, PRES, sepsis‐associated encephalopathy, central nervous system infections, and cerebrovascular events. In kidney transplant recipients, seizures are more frequently associated with electrolyte imbalance, hypertensive encephalopathy, dialysis disequilibrium syndrome, uremic encephalopathy, and PRES. Early postoperative hyponatremia, renal dysfunction, severe metabolic abnormalities, elevated tacrolimus concentrations, malnutrition, and severe systemic infection represent major risk factors for seizure development. Diagnostic evaluation relies on biochemical assessment, immunosuppressant level monitoring, neuroimaging, and electroencephalography, particularly in patients with persistent encephalopathy or suspected non‐convulsive status epilepticus. Based on the synthesized evidence, a practical diagnostic and management algorithm was proposed integrating early stabilization, etiological stratification, neurodiagnostic assessment, and targeted therapy. Acute symptomatic seizures after pediatric liver and kidney transplantation arise from heterogeneous and frequently overlapping mechanisms. Early identification of reversible triggers and individualized management are essential to reduce neurological morbidity and improve outcomes. The proposed diagnostic and management framework may support earlier recognition, structured evaluation, and targeted treatment of acute symptomatic seizures in pediatric transplant recipients.
  • Venous reconstruction in living donor liver transplantation: lessons learned from a new national program in a resource-limited setting
    K. Semash, T. Dzhanbekov, M. Nasirov, A. Subanov, B. Umarov
    Transplant International Official Journal of the European Society for Organ Transplantation, 2026
    Complex venous outflow reconstruction in living donor liver transplantation (LDLT) is technically demanding, particularly in resource-limited settings lacking consistent access to synthetic or cryopreserved grafts. We retrospectively analyzed 45 consecutive LDLTs performed during the initiation of a national program. Venous anatomy was evaluated using preoperative CT volumetry and intraoperative findings. Reconstruction strategies included direct anastomosis, unification venoplasty, PTFE grafts, and autologous conduits (falciform ligament, umbilical vein). Outcomes were compared between patients with (n = 17) and without (n = 28) venoplasty. Additional venous reconstruction was required in 37.8% of cases. In 6.7%, anatomically indicated veins could not be reconstructed due to lack of suitable conduits. No early venous thrombosis occurred, and all autologous conduits remained patent during follow-up. Small-for-size physiology developed in 11.1% of recipients, resolved conservatively, and was not associated with unreconstructed major veins. Major morbidity (Clavien–Dindo ≥ IIIb) occurred in 42.2%. The 90-day mortality rate was 11.1%, and 3-year survival was 82.2%, without significant differences between groups. In a newly established program within a resource-limited setting, predominantly autologous venoplasty was feasible and provided satisfactory early and mid-term outcomes.
  • De novo malignancies after liver transplantation: epidemiology, risk factors, and management strategies
    K. O. Semash, T. A. Dzhanbekov, M. M. Nasirov, Q. M. Umarov, A. B. Khudaybergenova
    Vestnik Transplantologii I Iskusstvennykh Organov, 2026
    Background. Liver transplantation (LT) significantly improves survival in patients with end-stage liver disease; however, it is associated with an increased risk of developing de novo malignancies. Long-term immunosuppression, viral infections, and unhealthy lifestyle choices increase the risk of post-transplant oncological complications. Objective: to summarize current evidence on the prevalence, risk factors, diagnostic, prevention, and treatment of de novo malignancies in liver transplant recipients. Materials and methods. This paper presents a literature review, including retrospective and prospective studies, meta-analyses, and clinical guidelines published over the past two decades. Results. The most common post-transplant malignancies include non-melanoma skin cancer, lymphoproliferative disorders, and solid organ tumors. Major risk factors are prolonged immunosuppression, viral infections, smoking, alcohol use, advanced recipient age, and the underlying liver disease. Current management strategies involve immunosuppression reduction, surgical resection, chemotherapy, and targeted therapy. In particular, mammalian target of rapamycin (mTOR) inhibitors have demonstrated antitumor efficacy in selected patients, particularly those with Kaposi’s sarcoma and lymphoproliferative disorders. Conclusion. Given the high oncological risk, stratified screening programs and individualized patient management are necessary after LT. Immunosuppression reduction, lifestyle modification, and early detection of malignancies are key factors in improving long-term outcomes.
  • Implementation of a pediatric kidney transplantation program in Uzbekistan: Feasibility and early outcomes
    Konstantin Semash, Akrom Akhmedov, Timur Dzhanbekov, Qosimjon Umarov, Jurabek Dustmurodov
    World Journal of Transplantation, 2025
    BACKGROUND Pediatric kidney transplantation is the treatment of choice for children with end-stage renal disease; however, access to transplantation remains limited in low- and middle-income countries. Uzbekistan had no prior institutional experience in performing pediatric living donor kidney transplantation (LDKT). AIM To report the implementation, surgical protocols, and clinical outcomes of the first pediatric LDKT program in Uzbekistan. METHODS This retrospective single-center study analyzed the first 20 pediatric LDKTs performed between April 2023 and February 2025. All donors were related family members who underwent either open or laparoscopic hand-assisted nephrectomy. Pre-transplant immunologic workup included HLA typing and anti-HLA antibody screening using solid-phase assays. Perioperative management was guided by Enhanced Recovery After Surgery Society principles. Primary outcomes included operative metrics, perioperative complications, graft function, biopsy-proven rejection, and patient/graft survival. Statistical analysis utilized descriptive statistics, Kaplan–Meier survival estimates, and Fisher’s exact test where applicable. RESULTS Donors included 13 women and 7 men (median age: 38 years; range: 31–50). Median operative times were 182.5 minutes for open nephrectomy and 198.5 minutes for laparoscopic nephrectomy. No major intraoperative complications occurred; one donor developed a postoperative wound seroma. All recipients (aged 87–207 months) exhibited immediate graft function, with no delayed graft function observed. Median cold and warm ischemia times were 15 minutes (range: 10–138) and 35 minutes (range: 18–40), respectively. Median serum creatinine decreased from 198 μmol/L on postoperative day 1 to 54 μmol/L by day 7. Three rejection episodes were reported, two of which occurred in sensitized recipients. Two graft losses were attributed to late rejection. One patient died from hemorrhagic stroke six months post-transplant. At 24 months, patient and graft survival rates were 95% and 90%, respectively. CONCLUSION The successful implementation of a pediatric living donor kidney transplantation program in Uzbekistan yielded favorable short- and intermediate-term outcomes, with high graft survival and low complication rates. This experience may provide a practical framework for initiating similar programs in other resource-constrained healthcare settings.
  • Diagnostic challenges and treatment approaches for hydatid cysts in atypical localizations
    Konstantin Semash, Mikhail Voskanov
    World Journal of Nephrology, 2025
    Hydatid disease, caused by the Echinococcus granulosus parasite, is traditionally associated with liver and lung involvement. However, recent years have seen an increase in cases with atypical localizations, such as the kidneys, thyroid, soft tissues, and bones. The study by Celik et al presents a series of five clinical cases where hydatid cysts were found in these rare anatomical regions, challenging conventional diagnostic and therapeutic approaches. The paper emphasizes the importance of differential diagnosis, as these cases can mimic other conditions, such as cancer, abscesses, or cysts. Advanced imaging techniques, such as computed tomography, magnetic resonance imaging, and ultrasound, play a crucial role in accurate diagnosis and help avoid misdiagnosis. The study demonstrates that early diagnosis and appropriate treatment of echinococosis in atypical localizations are critical for preventing complications like cyst rupture and secondary infections. The use of albendazole and surgical intervention, especially in combination with modern imaging techniques, yields good outcomes in these patients. However, several unanswered questions remain: What are the precise criteria for selecting the optimal treatment method in each case? What is the long-term effectiveness of different approaches? Do patients with hydatid cysts in atypical locations require additional monitoring and preventive treatment to avoid recurrence? Addressing these questions requires further research, and a multidisciplinary approach involving radiologists, surgeons, and infectious disease specialists is essential to optimize diagnosis and treatment. Early and accurate diagnostic methods based on differential diagnosis play a key role in improving treatment outcomes and reducing morbidity.
  • Redefining the treatment paradigm for esophageal gastrointestinal stromal tumors: The emerging role of endoscopic resection
    Konstantin Semash, Timur Dzhanbekov
    World Journal of Gastroenterology, 2025
    Esophageal gastrointestinal stromal tumors (GISTs) are exceedingly rare, often detected incidentally due to their asymptomatic nature. Historically, esophagectomy or enucleation has been the standard treatment, but these procedures carry significant morbidity. The retrospective study by Xu et al provides compelling evidence that endoscopic resection (ER) is a viable, minimally invasive alternative for low-risk esophageal GISTs, demonstrating a high en bloc resection rate (96.9%) and favorable long-term oncologic outcomes, including a 5-year overall survival rate of 100% and disease-free survival of 90.6%. These results challenge the conventional surgical paradigm and highlight the need for a paradigm shift towards endoscopic approaches in carefully selected patients. However, several critical questions remain unanswered: What are the precise selection criteria for ER candidacy? How does ER compare to traditional surgical methods in terms of recurrence risk and long-term functional outcomes? Could neoadjuvant therapy enhance the feasibility of ER for larger lesions? As endoscopic techniques continue to evolve, interdisciplinary collaboration among gastroenterologists, oncologists, and surgeons will be crucial to refining treatment algorithms and optimizing patient outcomes. Future prospective studies and randomized trials are warranted to solidify the role of ER as the standard of care for esophageal GISTs.
  • Bortezomib as a Potential Treatment for Recurrent Autoimmune Hepatitis Following Pediatric Liver Transplantation
    Konstantin Semash, Timur Dzhanbekov, Mansur Nasirov, Artem Monakhov, Patimat Gadzhieva
    Pediatric Transplantation, 2025
    BackgroundAutoimmune hepatitis (AIH) is a chronic inflammatory liver disease that can progress to liver cirrhosis and end‐stage liver disease, often necessitating liver transplantation (LT). Pediatric LT has significantly improved survival outcomes, but complications such as acute steroid‐resistant rejection and AIH recurrence pose serious challenges.Case PresentationWe report the first documented pediatric liver transplantation case in Uzbekistan, performed on a 14‐year‐old boy with liver cirrhosis secondary to AIH. Despite successful surgery, the patient developed acute steroid‐resistant graft rejection and was unresponsive to pulse methylprednisolone therapy and anti‐thymocyte globulin (ATG), which also induced adverse effects, including polyneuropathy and hypertension. Further evaluation revealed reactivation of AIH, confirmed by elevated ANA and ANCA titers. Conventional therapies failed to control the disease, prompting the use of bortezomib, a proteasome inhibitor. After the initial dose of bortezomib, significant improvement in bilirubin levels and liver synthetic function was observed. A second dose, administered 7 days later, resulted in the normalization of liver function markers and serological antibodies by postoperative Day 30. The patient was discharged in stable condition under a triple immunosuppressive regimen. To the best of our knowledge, we report the first documented case of using bortezomib for the treatment of recurrent autoimmune hepatitis in a pediatric patient following liver transplantation.ConclusionThis case emphasizes the effective use of bortezomib as a rescue therapy for steroid‐resistant rejection and the recurrence of autoimmune hepatitis following pediatric liver transplantation. It highlights the significance of alternative therapeutic approaches in addressing complex post‐transplant immune complications. Furthermore, this case prompts crucial considerations for future research, such as the monitoring of autoimmune disease reactivation and the potential role of drugs like bortezomib in managing immune‐related complications after liver transplantation.
  • Exploring the utility of near-infrared spectroscopy in liver transplantation: insights and challenges
    Ravshan Ibadov, Konstantin Semash, Mirshavkat Akbarov, Timur Dzhanbekov, Oybek Omonov, et al.
    Clinical Transplantation and Research, 2025
    Maintaining adequate tissue perfusion and oxygen delivery to the transplanted liver is critical for positive patient outcomes. Near-infrared spectroscopy (NIRS) has emerged as a promising tool for evaluating graft function in liver transplantation, particularly in assessing tissue perfusion. This review consolidates current knowledge regarding the application of NIRS in liver transplantation, highlighting its potential for noninvasive, continuous monitoring of liver perfusion and early detection of hemodynamic disturbances. Initial studies demonstrate the sensitivity of NIRS in evaluating liver oxygenation, with significant correlations observed between NIRS readings and biochemical markers of liver function. However, the effectiveness of NIRS can be influenced by factors such as subcutaneous fat thickness and patient positioning. Recent advancements also suggest that NIRS may assist in predicting graft fibrosis and other long-term complications. More extensive studies are required to establish standardized protocols and validate the clinical utility of NIRS in liver transplantation.
  • Portal Vein Stenosis Management in the Long-Term After Living Donor Liver Transplant
    Experimental and Clinical Transplantation, 2025
  • Large-for-size syndrome prophylaxis in infant liver recipients with low body mass
    Konstantin Semash, Timur Dzhanbekov
    World Journal of Transplantation, 2025
    Transplantation of the left lateral section (LLS) of the liver is now an established practice for treating advanced diffuse and unresectable focal liver diseases in children, with variants of the LLS primarily used in infants. However, the surgical challenge of matching the size of an adult donor's graft to the volume of a child's abdomen remains significant. This review explores historical developments, various approaches to measuring the required functional liver mass, and techniques to prevent complications associated with large-for-size grafts in infants.
  • Laparoscopic donor hepatectomy: Are there obstacles on the path to global widespread?
    Konstantin Semash, Timur Dzhanbekov
    Laparoscopic Endoscopic and Robotic Surgery, 2025
  • LAPAROSCOPIC AND ROBOTIC HEPATECTOMY IN LIVING LIVER DONORS. CURRENT STATE AND PROSPECTS
    K. O. Semash
    Vestnik Transplantologii I Iskusstvennykh Organov, 2025
  • Primary outcomes after major anatomical liver resections in infants at the National Children’s Medical Center
    K.O. Semash, T.A. Dzhanbekov
    Pirogov Russian Journal of Surgery, 2025
  • Kaposi sarcoma of a liver graft in living donor liver transplantation: a rare case report
    Umid Salimov, Palat Balachandran, Konstantin Semash
    Clinical Transplantation and Research, 2025
  • SUCCESSFUL LIVER TRANSPLANTATION IN A CRITICALLY UNDERWEIGHT PATIENT: A CASE REPORT
    Vestnik Transplantologii I Iskusstvennykh Organov, 2025
  • Laparoscopic Kasai portoenterostomy for biliary atresia: first experience from Central Asia
    Konstantin Semash, Mansur Nasirov, Timur Dzhanbekov, Ayimgul Khudaybergenova
    Frontiers in Pediatrics, 2025
  • LEMENTATION OF ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOLS IN LIVER TRANSPLANTATION
    K. O. Semash, T. A. Dzhanbekov, M. M. Nasyrov, D. R. Sabirov
    Vestnik Transplantologii I Iskusstvennykh Organov, 2025
  • PEDIATRIC LIVER TRANSPLANTATION IN UZBEKISTAN: FIRST CLINICAL CASE AND OUTCOME ANALYSIS
    K. O. Semash, T. A. Dzhanbekov, M. M. Nasyrov, A. R. Monakhov, P. M. Gadzhieva, et al.
    Vestnik Transplantologii I Iskusstvennykh Organov, 2025
  • Evaluation and Management of Living Donors in the Setting of Living Donor Liver Transplant Program in the Republic of Uzbekistan
    Konstantin Semash
    Experimental and Clinical Transplantation, 2024
  • Robotic surgery in living liver donors and liver recipients
    Konstantin Semash
    Laparoscopic Endoscopic and Robotic Surgery, 2024
  • Anastomosing hemangioma of the liver in infant: A case report
    Konstantin Semash, Timur Dzhanbekov, Murat Abduazizov, Sukhrob Tashmatov
    Journal of Pediatric Surgery Case Reports, 2024
  • Liver Graft Machine Perfusion: From History Perspective to Modern Approaches in Transplant Surgery
    Konstantin Semash, Umid Salimov, T. Dzhanbekov, Djakhongir Sabirov
    Experimental and Clinical Transplantation, 2024
  • Implementation of a living donor liver transplantation program in the Republic of Uzbekistan: a report of the first 40 cases
    Konstantin Semash, Timur Dzhanbekov, Mirshavkat Akbarov, Miraziz Mirolimov, Azimjon Usmonov, et al.
    Clinical Transplantation and Research, 2024
  • POST-liVer TranSPlanT BiliarY cOMPlicaTiOnS
    K. O. Semash
    Vestnik Transplantologii I Iskusstvennykh Organov, 2024
  • Robotic surgery in the aspect of liver transplantation
    K. O. Semash
    Transplantologiya the Russian Journal of Transplantation, 2024
  • RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION – EXPERIENCE FROM THE DEPARTMENT OF HEPATOBILIARY SURGERY
    K. O. Semash, T. A. Dzhanbekov
    Vestnik Transplantologii I Iskusstvennykh Organov, 2024
  • Case Report: Major right-sided hepatectomies in infants in Uzbekistan: a case series
    K. Semash, T. Dzhanbekov, S. Islomov
    Frontiers in Pediatrics, 2024
  • Single-center experience of intraoperative ligation of the splenic artery for prevention of splenic artery steal syndrome in patients after living donor liver transplant
    K. O. Semash, T. A. Dzhanbekov, T. Z. Gaybullaev
    Transplantologiya the Russian Journal of Transplantation, 2024
  • Reconstructive interventions on bile ducts in patients with benign obstructive jaundice
    K. O. Semash, T. A Dzhanbekov, M. M. Akbarov, T. Z. Gaybullaev
    Annals of HPB Surgery, 2024
  • VASCULAR COMPLICATIONS AFTER LIVER TRANSPLANTATION: CONTEMPORARY APPROACHES TO DETECTION AND TREATMENT. A LITERATURE REVIEW
    K. O. Semash, T. A. Dzhanbekov, M. M. Akbarov
    Vestnik Transplantologii I Iskusstvennykh Organov, 2023
  • Living donor left lateral sectionectomy: Should the procedure still be performed open?
    Artem Monakhov, Sergey Gautier, Olga Tsiroulnikova, Konstantin Semash, Robert Latypov, et al.
    Journal of Liver Transplantation, 2021
  • Review of surgical techniques for performing laparoscopic donor hepatectomy
    K. O. Semash, S. V. Gautier
    Vestnik Transplantologii I Iskusstvennykh Organov, 2020
  • The role of endovascular and endobiliary methods in the treatment of post-liver transplant complications
    S. V. Gautier, M. A. Voskanov, A. R. Monakhov, K. O. Semash
    Vestnik Transplantologii I Iskusstvennykh Organov, 2020
  • Treatment of biliodigestive anastomotic strictures after transplantation of left lateral segment of the liver
    A. R. Monakhov, B. L. Mironkov, M. A. Voskanov, S. V. Meshcheryakov, E. T. Azoev, et al.
    Vestnik Transplantologii I Iskusstvennykh Organov, 2020
  • Split liver transplantation: a single center experience
    S. V. Gautier, A. R. Monakhov, O. M. Tsiroulnikova, R. A. Latypov, T. A. Dzhanbekov, et al.
    Almanac of Clinical Medicine, 2020
  • Simultaneous laparoscopic left lateral sectionectomy and nephrectomy in the same living donor: The first case report
    Sergey Gautier, Artem Monakhov, Igor Miloserdov, Sergey Arzumanov, Olga Tsirulnikova, et al.
    American Journal of Transplantation, 2019
  • Laparoscopic left lateral section procurement in living liver donors: A single center propensity score-matched study
    Sergey Gautier, Artem Monakhov, Eduard Gallyamov, Olga Tsirulnikova, Evgeny Zagaynov, et al.
    Clinical Transplantation, 2018
  • Correction of extrahepatic portal hypertension in pediatric patient after liver transplantation
    A. R. Monakhov, B. L. Mironkov, T. A. Dzhanbekov, K. O. Semash, Kh. M. Khizroev, et al.
    Vestnik Transplantologii I Iskusstvennykh Organov, 2017

RECENT SCHOLAR PUBLICATIONS

  • Venous reconstruction in living donor liver transplantation: lessons learned from a new national program in a resource-limited setting
    K Semash, T Dzhanbekov, M Nasirov, A Subanov, B Umarov
    Transplant International 39, 15985 , 2026
    2026
  • Neurological Complications After Pediatric Liver and Kidney Transplantation: A Comprehensive Review of Acute Symptomatic Seizures
    S Konstantin, D Timur, N Mansur, U Bakhtiyorjon, Q Navruz, K Bakhtiyor
    Pediatric Transplantation 30 (5), e70341 , 2026
    2026
  • De novo злокачественные новообразования после трансплантации печени: эпидемиология, факторы риска и стратегии ведения
    КО Сёмаш, ТА Джанбеков, ММ Насыров, КМ Умаров, ...
    Вестник трансплантологии и искусственных органов 28 (1), 47-63 , 2026
    2026
  • Педиатрическая трансплантация печени в Узбекистане: первый клинический случай и анализ результатов
    КО Сёмаш, ТА Джанбеков, ММ Насыров, АР Монахов, ПМ Гаджиева, ...
    Вестник трансплантологии и искусственных органов 27 (4), 67-73 , 2026
    2026
  • Генитальные аномалии при персистирующей клоаке
    НШ Эргашев, КМ Умаров, ММ Насыров, КО Сёмаш, ТА Джанбеков, ...
    Cərrahiyyə 2026 (1), 92-97 , 2026
    2026
  • Implementation of a pediatric kidney transplantation program in Uzbekistan: Feasibility and early outcomes
    K Semash, A Akhmedov, T Dzhanbekov, Q Umarov, J Dustmurodov
    World Journal of Transplantation 15 (4), 107728 , 2025
    2025
  • Laparoscopic Kasai Portoenterostomy for Biliary Atresia: First Experience from Central Asia
    K Semash, M Nasirov, T Dzhanbekov, A Khudaybergenova
    Frontiers in Pediatrics 13, 1666539 , 2025
    2025
  • Diagnostic challenges and treatment approaches for hydatid cysts in atypical localizations
    K Semash, M Voskanov
    World Journal of Nephrology 14 (3), 107955 , 2025
    2025
    Citations: 5
  • Применение протоколов ускоренного восстановления после хирургического вмешательства (ERAS) в трансплантации печени
    КО Семаш, ТА Джанбеков, ММ Насыров, ДР Сабиров
    Вестник трансплантологии и искусственных органов 27 (3), 46-54 , 2025
    2025
  • Случай успешной трансплантации печени пациенту с критически низкой массой тела
    КО Сёмаш, ТА Джанбеков, РА Ибадов
    Вестник трансплантологии и искусственных органов 27 (2), 39-45 , 2025
    2025
  • Redefining the treatment paradigm for esophageal gastrointestinal stromal tumors: The emerging role of endoscopic resection
    K Semash, T Dzhanbekov
    World Journal of Gastroenterology 31 (24), 106440 , 2025
    2025
    Citations: 1
  • Bortezomib as a potential treatment for recurrent autoimmune hepatitis following pediatric liver transplantation
    K Semash, T Dzhanbekov, M Nasirov, A Monakhov, P Gadzhieva
    Pediatric Transplantation 29 (4), e70082 , 2025
    2025
    Citations: 2
  • Portal Vein Stenosis Management in the Long-Term After Living Donor Liver Transplant
    K Semash, T Dzhanbekov, A Usmonov
    Experimental and clinical transplantation: official journal of the Middle … , 2025
    2025
  • Лапароскопическая и роботизированная резекция печени в аспекте родственного донорства. Современное состояние и перспективы развития направления
    КО Сёмаш
    Вестник трансплантологии и искусственных органов 27 (1), 145-159 , 2025
    2025
  • Large-for-size syndrome prophylaxis in infant liver recipients with low body mass
    K Semash, T Dzhanbekov
    World Journal of Transplantation 15 (1), 99452 , 2025
    2025
    Citations: 3
  • Exploring the utility of near-infrared spectroscopy in liver transplantation: insights and challenges
    R Ibadov, K Semash, M Akbarov, T Dzhanbekov, O Omonov, A Usmonov, ...
    Clinical transplantation and research , 2025
    2025
    Citations: 2
  • Laparoscopic donor hepatectomy: Are there obstacles on the path to global widespread?
    K Semash, T Dzhanbekov
    Laparoscopic, Endoscopic and Robotic Surgery 8 (1), 13-22 , 2025
    2025
  • Primary outcomes after major anatomical liver resections in infants at the National Children's Medical Center
    KO Semash, TA Dzhanbekov
    Khirurgiia, 86-94 , 2025
    2025
  • Kaposi sarcoma of a liver graft in living donor liver transplantation: a rare case report
    U Salimov, P Balachandran, K Semash
    Clinical transplantation and research 39 (1), 77-83 , 2025
    2025
    Citations: 1
  • Case Report: Major right-sided hepatectomies in infants in Uzbekistan: a case series
    K Semash, T Dzhanbekov, S Islomov
    Frontiers in Pediatrics 12, 1495165 , 2025
    2025
    Citations: 1

MOST CITED SCHOLAR PUBLICATIONS

  • Laparoscopic left lateral section procurement in living liver donors: A single center propensity score‐matched study
    S Gautier, A Monakhov, E Gallyamov, O Tsirulnikova, E Zagaynov, ...
    Clinical transplantation 32 (9), e13374 , 2018
    2018
    Citations: 50
  • Implementation of a living donor liver transplantation program in the Republic of Uzbekistan: a report of the first 40 cases
    K Semash, T Dzhanbekov, M Akbarov, M Mirolimov, A Usmonov, ...
    Clinical transplantation and research 38 (2), 116-127 , 2024
    2024
    Citations: 27
  • Vascular complications after liver transplantation: contemporary approaches to detection and treatment. A literature review
    KO Semash, TA Dzhanbekov, MM Akbarov
    Russian Journal of Transplantology and Artificial Organs 25 (4), 46-72 , 2023
    2023
    Citations: 18
  • Review of surgical techniques for performing laparoscopic donor hepatectomy
    KO Semash, SV Gautier
    Russian Journal of Transplantology and Artificial Organs 22 (4), 149-153 , 2020
    2020
    Citations: 16
  • The role of endovascular and endobiliary methods in the treatment of post-liver transplant complications
    SV Gautier, MA Voskanov, AR Monakhov, KO Semash
    Russian Journal of Transplantology and Artificial Organs 22 (4), 140-148 , 2020
    2020
    Citations: 14
  • Роль эндоваскулярных и эндобилиарных методов в лечении осложнений после трансплантации печени
    СВ Готье, МА Восканов, АР Монахов, КО Сёмаш
    Вестник трансплантологии и искусственных органов 22 (4), 140-148 , 2021
    2021
    Citations: 13
  • Living donor left lateral sectionectomy: Should the procedure still be performed open?
    A Monakhov, S Gautier, O Tsiroulnikova, K Semash, R Latypov, ...
    Journal of Liver Transplantation 1, 100001 , 2021
    2021
    Citations: 13
  • Simultaneous laparoscopic left lateral sectionectomy and nephrectomy in the same living donor: The first case report
    S Gautier, A Monakhov, I Miloserdov, S Arzumanov, O Tsirulnikova, ...
    American Journal of Transplantation 19 (6), 1847-1851 , 2019
    2019
    Citations: 13
  • Split liver transplantation: a single center experience
    SV Gautier, AR Monakhov, OM Tsiroulnikova, RA Latypov, ...
    Almanac of Clinical Medicine 48 (3), 162-170 , 2020
    2020
    Citations: 11
  • Сплит-трансплантация печени: опыт одного центра
    S Gautier, A Monakhov, O Tsiroulnikova, R Latypov, T Dzhanbekov, ...
    Альманах клинической медицины 48 (3), 162-170 , 2020
    2020
    Citations: 11
  • Laparoscopic left lateral sectionectomy in living liver donors: from the first experience to routine usage
    A Monakhov, K Semash, O Tsiroulnikova, T Djanbekov, K Khizroev, ...
    Transplantation 104 (S3), S241 , 2020
    2020
    Citations: 10
  • Robotic surgery in living liver donors and liver recipients
    K Semash
    Laparoscopic, Endoscopic and Robotic Surgery 7 (3), 123-127 , 2024
    2024
    Citations: 9
  • Stages Of Preparation And Examination Of Related Liver Donors And Their Perioperative Management
    КО Semash, ТА Janbekov, ММ Akbarov, АА Usmonov, TZ Gaibullaev
    Coloproctology and Endoscopic Surgery in Uzbekistan, 41-54 , 2023
    2023
    Citations: 8
  • Evaluation and Management of Living Donors in the Setting of Living Donor Liver Transplant Program in the Republic of Uzbekistan
    K Semash
    Experimental and Clinical Transplantation 22 (9), 664-674 , 2024
    2024
    Citations: 7
  • Liver Graft Machine Perfusion: From History Perspective to Modern Approaches in Transplant Surgery
    K Semash, U Salimov, T Dzhanbekov, D Sabirov
    Experimental and Clinical Transplantation 22 (7), 497-508 , 2024
    2024
    Citations: 7
  • Сосудистые осложнения после трансплантации печени–современные методы диагностики и лечения. Обзор мировой литературы.
    КО Сёмаш, ТА Джанбеков, ММ Акбаров
    Вестник трансплантологии и искусственных органов 25 (4), 46-72 , 2023
    2023
    Citations: 7
  • Laparoscopic approach in liver harvesting from living donors for transplantation in children
    SV Gautier, AR Monakhov, EA Gallyamov, EV Zagaynov, OM Tsirulnikova, ...
    Annaly khirurgicheskoy gepatologii= Annals of HPB Surgery 23 (1), 13-18 , 2018
    2018
    Citations: 7
  • Laparoscopic donor hepatectomy in settings of pediatric living donor liver transplantation: single center experience
    A Monakhov, K Semash, M Boldyrev, S Mescheryakov, S Gautier
    Korean Journal of Transplantation 36 (Supple 1), S354 , 2022
    2022
    Citations: 6
  • Лапароскопическое изъятие левого латерального сектора печени у прижизненного донора
    КО Сёмаш
    ФГБУ "Национальный медицинский исследовательский центр трансплантологии и … , 2020
    2020
    Citations: 6
  • Лапароскопический забор фрагментов печени от живого родственного донора для трансплантации детям
    СВ Готье, АР Монахов, ЭА Галлямов, ЕВ Загайнов, ОМ Цирульникова, ...
    Анналы хирургической гепатологии 23 (1), 13-18 , 2018
    2018
    Citations: 6